0

Molecular Diagnostics Market Global Report 2020-30

Region:Global

Author(s):

Product Code:7617

Download Sample Report download
Buy the Full ReportStarting from $4000
Published on

April 2020

Total pages

200

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $4000

About the Report

About the Report

The molecular diagnostics market consists of sales of molecular diagnostics services and related products. Molecular diagnostics is a term used to describe a class of techniques that are used to examine biological markers in the genetic code (genome) of an organism and to determine how their cells express their genes as proteins.
 
The global molecular diagnostics market was worth USD 8.62 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 8.82% and reach USD 12.09 billion by 2023.
 
The molecular diagnostics market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region in 2019.
 
The molecular diagnostics market covered in this report is segmented by technology into polymerase chain rreaction (PCR); DNA sequencing; next-generation sequencing. It is also segmented by product into instruments; reagents and consumables; software & services, by application into oncology; pharmacogenomics; infectious diseases; genetic testing; neurological disease; cardiovascular disease; microbiology; others and by end-user into hospitals; laboratories; others (blood banks, home health agencies, and nursing homes)
 
The global prevalence of infectious diseases and cancers of different forms drives the molecular diagnostics market. The increasing prevalence of infectious diseases and various types of cancer creates a demand for new diagnostic procedures including fast and specific molecular diagnostic tests. According to the International Agency for Research on Cancer (IARC), in 2018, there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide, and by 2040, the number is expected to increase to 27.5 million new cancer cases and 16.3 million cancer. The increasing prevalence of cancer globally increases the demand for molecular diagnostic tests for effective diagnosis of cancer over the coming years, thereby contributing to the growth of the market.
 
The complex regulatory frameworks delaying the approval of new molecular diagnostics tests is a key factor hampering the growth of the molecular diagnostics market. The requirements of the FDA for the tests are changing and thereby increasing the time required to obtain pre-market approval. For instance, in 2013, the FDA has tried to establish a new regulatory system for LDTs (laboratory-developed tests) that are officially governed under the Clinical Laboratory Improvement Amendments (CLIA) and does not come under the purview of the FDA. However in 2017 senior officials circulated a draft proposal known as the Diagnostic Accuracy and Innovation Act (DAIA) to serve as the basis for the creation of a new regulatory system for LDTs. The complexity involved in regulatory and legal requirements that applies to molecular diagnostics tests is expected to limit the growth of the molecular diagnostics market.
 
The advances in genomics and proteomics is a key trend driving the growth of the molecular diagnostics market. Polymerase chain reaction (PCR) is a recent development in genomics and helps in discovering new approaches to molecular diagnosis for disease diagnosis and pathogenesis of diseases. This enables better monitoring and a fast diagnosis and major organizations are investing to have a competitive edge. Following the trend, Genome Canada, a source of funding for genomics and proteomics, announced plans to invest USD 16 million between the period April 2015 and March 2017. The growing research in proteomics and genomics will help develop more advanced molecular diagnostic techniques in the forecast period.
 
In August 2018, Bruker Corporation, an American based manufacturer of scientific instruments for molecular and materials research announced plans to acquire majority stake in Hain Lifescience GmbH for undisclosed amount. This acquisition will help Bruker to expand its presence in attractive microbiology and virology infectious disease MDx markets, and add tuberculosis and mycobacteria testing, virology and in human genetics MDx, and a pipeline for multiplex syndromic panel testing to it's portfolio. Hain Lifescience GmbH is an infectious disease molecular diagnostics (MDx) specialist and provides solutions for detecting microbial and viral pathogens, antibiotic resistance testing, and human genetic diseases.
 
Major players in the market are Becton, BioMerieux SA., Danaher Corporation, Grifols, Hologic Inc., Novartis AG, QIAGEN, Siemens Healthcare GmbH, Abbott and Dickinson and Company.

Products

Products

1) By Technology: Polymerase Chain Rreaction (PCR); DNA Sequencing; Next-Generation Sequencing; 2) By Product: Instruments; Reagents and Consumables; Software & Services; 3) By Application: Oncology; Pharmacogenomics; Infectious Diseases; Genetic Testing; Neurological Disease; Cardiovascular Disease; Microbiology; Others; 4)By End-User: Hospitals; Laboratories; Others (Blood Banks, Home Health Agencies, and Nursing Homes)


Companies

Becton; BioMerieux SA.; Danaher Corporation; Grifols; Hologic Inc.; Novartis AG; QIAGEN; Siemens Healthcare GmbH; Abbott; Dickinson and Company; Hoffmann-La Roche Ltd.; BD; Bio-Rad Laboratories; Johnson & Johnson; Cepheid; Roche Diagnostics; Alere; Bayer AG; Dako; Sysmex Corporation; Agilent Technologies; Diasorin; Illumina; Thermo Fisher Scientific; Biocartis Group NV; Other players

Table of Contents

Table of Contents

1. Executive Summary

2. Molecular Diagnostics Market Characteristics

3. Molecular Diagnostics Market Size And Growth

3.1. Global Molecular Diagnostics Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Molecular Diagnostics Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Molecular Diagnostics Market Segmentation

4.1. Global Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Polymerase Chain Rreaction (PCR)

DNA Sequencing

Next-Generation Sequencing

4.2. Global Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Instruments

Reagents and Consumables

Software & Services

4.3. Global Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Oncology

Pharmacogenomics

Infectious Diseases

Genetic Testing

Neurological Disease

Cardiovascular Disease

Microbiology

Others

4.4. Global Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Hospitals

Laboratories

Others (Blood Banks, Home Health Agencies, and Nursing Homes)

5. Molecular Diagnostics Market Regional And Country Analysis

5.1. Global Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Molecular Diagnostics Market

6.1. Asia-Pacific Molecular Diagnostics Market Overview

6.2. Asia-Pacific Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Molecular Diagnostics Market

7.1. China Molecular Diagnostics Market Overview

7.2. China Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Molecular Diagnostics Market

8.1. India Molecular Diagnostics Market Overview

8.2. India Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Molecular Diagnostics Market

9.1. Japan Molecular Diagnostics Market Overview

9.2. Japan Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Molecular Diagnostics Market

10.1. Australia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Molecular Diagnostics Market

11.1. Indonesia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Molecular Diagnostics Market

12.1. South Korea Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Molecular Diagnostics Market

13.1. Western Europe Molecular Diagnostics Market Overview

13.2. Western Europe Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Molecular Diagnostics Market

14.1. UK Molecular Diagnostics Market Overview

14.2. UK Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Molecular Diagnostics Market

15.1. Germany Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Molecular Diagnostics Market

16.3. France Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Molecular Diagnostics Market

17.1. Eastern Europe Molecular Diagnostics Market Overview

17.2. Eastern Europe Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Molecular Diagnostics Market

18.1. Russia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Molecular Diagnostics Market

19.1. North America Molecular Diagnostics Market Overview

19.2. North America Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Molecular Diagnostics Market

20.1. USA Molecular Diagnostics Market Overview

20.2. USA Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Molecular Diagnostics Market

21.1. South America Molecular Diagnostics Market Overview

21.2. South America Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Molecular Diagnostics Market

22.1. Brazil Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Molecular Diagnostics Market

23.1. Middle East Molecular Diagnostics Market Overview

23.2. Middle East Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Molecular Diagnostics Market

24.1. Africa Molecular Diagnostics Market Overview

24.2. Africa Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Molecular Diagnostics Market Competitive Landscape And Company Profiles

25.1. Molecular Diagnostics Market Competitive Landscape

25.2. Molecular Diagnostics Market Company Profiles

25.2.1. Becton

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. BioMerieux SA.

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Danaher Corporation

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Grifols

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Hologic Inc.

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Molecular Diagnostics Market

27. Molecular Diagnostics Market Trends And Strategies

28. Molecular Diagnostics Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

 


List of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Global Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: Global Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: Global Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: Asia-Pacific, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: China, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: India, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: Japan, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: Australia, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: Indonesia, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: South Korea, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: Western Europe, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: UK, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: Germany, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: France, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: Eastern Europe, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: Russia, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: North America, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: USA, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: South America, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: Brazil, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 26: Middle East, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 27: Africa, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 28: Becton Financial Performance

Figure 29: BioMerieux SA. Financial Performance

Figure 30: Danaher Corporation Financial Performance

Figure 31: Grifols Financial Performance

Figure 32: Hologic Inc. Financial Performance


List of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Global Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: Global Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: Global Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: Asia-Pacific, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: China, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: India, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: Japan, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: Australia, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: Indonesia, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: South Korea, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: Western Europe, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: UK, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: Germany, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: France, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: Eastern Europe, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: Russia, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: North America, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: USA, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: South America, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: Brazil, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 26: Middle East, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 27: Africa, Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 28: Becton Financial Performance

Table 29: BioMerieux SA. Financial Performance

Table 30: Danaher Corporation Financial Performance

Table 31: Grifols Financial Performance

Table 32: Hologic Inc. Financial Performance

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022